A new editorial was recently published in Oncotarget’s Volume 15, on July 10, 2024, entitled, “The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy.”
Alzheimer’s Blood Test Shows High Diagnostic Accuracy
A commercially available plasma assay that measured phosphorylated tau at threonine 217 (p-tau217) accurately identified biological Alzheimer’s disease, data from three cohorts showed. Across all